Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study

Patients with IBD were at an increased risk of infections, even among those naïve to IMM and advanced therapies. There was no significant difference in the risk of infections across advanced therapy exposures.

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2025-12-12
DOI
https://doi.org/10.1093/ecco-jcc/jjaf229
Citations
1
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
1.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study

Ola Olén, Hans Strid, Susanna Jäghult, Jonas Halfvarson et al.
1 citations
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
1.82
article

Risk of serious infections in patients with inflammatory bowel disease treated with biologic and small molecule therapies: a nationwide cohort study

Ola Olén, Hans Strid, Susanna Jäghult, Jonas Halfvarson, Karl Mårild, Ulrika L. Fagerberg, Pär Myrelid, Marie Andersson, Martin Rejler, Charlotte Hedin, Jonas Filip Ludvigsson, Pontus Nauclér, Henrik Hjortswang, Caroline A.M. Nordenvall, Jordan E. Axelrad, Jóhann P. Hreinsson, Anders Forss, Jonas Söderling, Olof Grip
article en
1 citations

Abstract

Patients with IBD were at an increased risk of infections, even among those naïve to IMM and advanced therapies. There was no significant difference in the risk of infections across advanced therapy exposures.

Journal of Crohn s and ColitisVol. 20(2)
National Academy of Medicine (US), Karolinska University Hospital (SE), Örebro University (SE), Sahlgrenska University Hospital (SE), Karolinska Institutet (SE), Drottning Silvias barn- och ungdomssjukhus (SE), Sachs' Children and Youth Hospital (SE), Örebro University Hospital (SE), New York University (US), Columbia University (US), University of Gothenburg (SE)
Openalex Percentile: Top 11%
Inflammatory Bowel Disease
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.